A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mirdametinib | CAS 391210-10-9 - Request Quote

Picture of Mirdametinib

Mirdametinib

SZ CAT No:SZ-M185001
CAS No
391210-10-9
Mol.F.
C16H14F3IN2O4
Mol.Wt.
482.2
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Mirdametinib is chemically (R)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide. Mirdametinib is supplied with detailed characterization data compliant with regulatory guideline. Mirdametinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mirdametinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 391210-10-9

Purchase 391210-10-9

Order 391210-10-9

Enquire 391210-10-9

price of 391210-10-9

391210-10-9 Supplier

391210-10-9 Manufacturer

391210-10-9 Exporter

buy high quality Mirdametinib

Purchase Mirdametinib

Mirdametinib suppliers

Mirdametinib manufacturers

Mirdametinib price

Order Mirdametinib

Enquire Mirdametinib

Mirdametinib cost

Mirdametinib Supplier

Mirdametinib Distributor

Mirdametinib for Method Validation

Mirdametinib Reference Standard

Mirdametinib for ANDA Filing

Mirdametinib for Forced Degradation Studies

Mirdametinib Identification Standards

Mirdametinib for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,